Mark D. Andrews, MD

Discovery of a Selective TRPM8 Antagonist with Clinical Efficacy in Cold-Related Pain. Andrews MD, Af Forselles K, Beaumont K, Galan SR, Glossop PA, Grenie M, Jessiman A, Kenyon AS, Lunn G, Maw G, Owen RM, Pryde DC, Roberts D, Tran TD. . 2015 Apr; 6(4):419-24.

Inhibition of TRPM8 channels reduces pain in the cold pressor test in humans. Winchester WJ, Gore K, Glatt S, Petit W, Gardiner JC, Conlon K, Postlethwaite M, Saintot PP, Roberts S, Gosset JR, Matsuura T, Andrews MD, Glossop PA, Palmer MJ, Clear N, Collins S, Beaumont K, Reynolds DS. J. Pharmacol. Exp. Ther. 2014 11; 351(2):259-69.

Clinical Inquiry: What is the best initial treatment for venous stasis ulcers?. Poynter E, Andrews M, Ackerman W. J Fam Pract. 2013 Aug; 62(8):433-4.

Hidden in plain sight: residency coordinators' social support of residents in family medicine residency programs. McCann WJ, Knudson M, Andrews M, Locke M, Davis SW. Fam Med. 2011 Sep; 43(8):551-5.

Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence. Andrews MD, Fish PV, Blagg J, Brabham TK, Brennan PE, Bridgeland A, Brown AD, Bungay PJ, Conlon KM, Edmunds NJ, af Forselles K, Gibbons CP, Green MP, Hanton G, Holbrook M, Jessiman AS, McIntosh K, McMurray G, Nichols CL, Root JA, Storer RI, Sutton MR, Ward RV, Westbrook D, Whitlock GA. Bioorg. Med. Chem. Lett. 2011 May; 21(9):2715-20.

Technology Transfer and Commercialization

Research Focus Areas

Translation to Care

More Resources

Mark D. Andrews, MD